Mariah M Johnson 1 , Sancy A Leachman * , 1 , Lisa G Aspinwall 2 , Lee D Cranmer 3 , Clara Curiel-Lewandrowski 4 , Vernon K Sondak 5 , Clara E Stemwedel 6 , Susan M Swetter 7 , John Vetto 6 , Tawnya Bowles 8 , Robert P Dellavalle 9 , Larisa J Geskin 10 , Douglas Grossman 2 , Kenneth F Grossmann 2 , Jason E Hawkes 2 , Joanne M Jeter 11 , Caroline C Kim 12 , John M Kirkwood 13 , Aaron R Mangold 14 , Frank Meyskens 15 , Michael E Ming 16 , Kelly C Nelson 17 , Michael Piepkorn 18 , Brian P Pollack 19 , June K Robinson 20 , Arthur J Sober 12 , Shannon Trotter 11 , Suraj S Venna 21 , Sanjiv Agarwala 22 , Rhoda Alani 23 , Bruce Averbook 24 , Anna Bar 6 , Mirna Becevic 25 , Neil Box 9 , William E Carson III 11 , Pamela B Cassidy 6 , Suephy C Chen 19 , Emily Y Chu 16 , Darrel L Ellis 26 , Laura K Ferris 13 , David E Fisher 27 , Kari Kendra 11 , David H Lawson 28 , Philip D Leming 29 , Kim A Margolin 30 , Svetomir Markovic 31 , Mary C Martini 20 , Debbie Miller 6 , Debjani Sahni 23 , William H Sharfman 32 , Jennifer Stein 33 , Alexander J Stratigos 34 , Ahmad Tarhini 13 , Matthew H Taylor 6 , Oliver J Wisco 35 , Michael K Wong 36
01 March 2017
Melanoma is usually apparent on the skin and readily detected by trained medical providers using a routine total body skin examination, yet this malignancy is responsible for the majority of skin cancer-related deaths. Currently, there is no national consensus on skin cancer screening in the USA, but dermatologists and primary care providers are routinely confronted with making the decision about when to recommend total body skin examinations and at what interval. The objectives of this paper are: to propose rational, risk-based, data-driven guidelines commensurate with the US Preventive Services Task Force screening guidelines for other disorders; to compare our proposed guidelines to recommendations made by other national and international organizations; and to review the US Preventive Services Task Force's 2016 Draft Recommendation Statement on skin cancer screening.